Form 13G ZimVie Inc. For: 14 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ZimVie Inc (ZIMV)
ZimVie Inc stock price live, this page displays NASDAQ ZIMV stock exchange data. View the ZIMV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ZimVie Inc real time stock price chart below.
What Is the ZimVie Inc Stock Price Today?
The ZimVie Inc stock price today is 18.99.
What Is the Stock Symbol for ZimVie Inc?
The stock symbol for ZimVie Inc is "ZIMV."
What Stock Exchange Does ZimVie Inc Trade On?
ZimVie Inc is listed and trades on the NASDAQ stock exchange.
Is ZimVie Inc a Good Stock to Buy?
Determining whether ZimVie Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZIMV quote. (ISIN: US98888T1079)
What Is the ZimVie Inc Stock Price Today?
The ZimVie Inc stock price today is 18.99.
What Is the Stock Symbol for ZimVie Inc?
The stock symbol for ZimVie Inc is "ZIMV."
What Stock Exchange Does ZimVie Inc Trade On?
ZimVie Inc is listed and trades on the NASDAQ stock exchange.
Is ZimVie Inc a Good Stock to Buy?
Determining whether ZimVie Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZIMV quote. (ISIN: US98888T1079)
NASDAQ
Currency in USD
18.99
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.99
19.00
52 wk Range
8.15
19.01
Showing ZimVie historical data. For real-time data please try another search
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.9919.00
52 wk Range
8.1519.01
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZIMV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
ZimVie Inc Company Profile
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was formerly known as Spine and Dental Businesses and changed its name to ZimVie Inc. in February 2022. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.
ZimVie Inc Earnings Call Summary for Q1/2025
- ZimVie reported Q1 2025 EPS of $0.27, beating expectations, with revenue of $112 million and a 238% increase in adjusted EPS year-over-year
- Despite a 5.2% revenue decrease, adjusted EBITDA rose 41% YoY to $17.6 million, reflecting improved profitability and cost management
- The company launched a new molar implant system and expanded digital dentistry solutions, positioning itself well in the premium implant market
- Full-year guidance projects revenue between $445-460 million and adjusted EBITDA of $65-70 million, with Q2 sales forecast at $112-114 million
- ZimVie's stock rose 3.26% in aftermarket trading, signaling investor confidence despite market challenges and anticipated tariff costs
Last Updated: 05/09/2025, 05:32 AM
Read Full TranscriptCompare ZIMV to Peers and Sector
Metrics to compare | ZIMV | Peers Peers - average of corresponding metrics from companies closely matching ZIMV: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZIMVPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 3.2x | |
Upside (Analyst Target) | 0.0% | 0.0% | 51.3% | |
Fair Value Upside | Unlock | 0.0% | 8.9% | Unlock |
Earnings
Latest Release
Mar 04, 2026
EPS / Forecast
-- / 0.1397
Revenue / Forecast
-- / 114.63M
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.